Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002911215 | SCV003647722 | uncertain significance | Inborn genetic diseases | 2022-10-27 | criteria provided, single submitter | clinical testing | The c.6523G>A (p.G2175S) alteration is located in exon 41 (coding exon 41) of the DYNC2H1 gene. This alteration results from a G to A substitution at nucleotide position 6523, causing the glycine (G) at amino acid position 2175 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |